Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Anglaret

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 31, 2010
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'IvoireEugène Messou, Marie-Laure Chaix, Delphine Gabillard, et al.
AIDS (London, England)|March 9, 2012
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing ageEric N Ouattara, Xavier Anglaret, Angela Y Wong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2011
Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'IvoireEugène Messou, Martial Kouakou, Delphine Gabillard, et al.
BMC Infectious Diseases|January 30, 2022
Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adultsDesmorys Raoul Moh, Jean-Baptiste Ntakpé, Delphine Gabillard, et al.
Antiviral Therapy|April 9, 2015
Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'IvoireAnders Boyd, Raoul Moh, Delphine Gabillard, et al.
BMJ Open|January 12, 2024
Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation modelAmir M Mohareb, Arthur Y Kim, Anders Boyd, et al.
Journal of Clinical Microbiology|June 16, 2005
Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited settingFrancois Rouet, Didier K Ekouevi, Marie-Laure Chaix, et al.
Plos Medicine|October 28, 2009
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalElena Losina, Hapsatou Touré, Lauren M Uhler, et al.
Plos One|June 6, 2017
High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'IvoireCalixte Ghehi, Delphine Gabillard, Raoul Moh, et al.
Antiviral Therapy|September 13, 2005
Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'IvoireRaoul Moh, Christine Danel, Souleymane Sorho, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Journal of Acquired Immune Deficiency Syndromes (1999)|December 31, 2010
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'IvoireEugène Messou, Marie-Laure Chaix, Delphine Gabillard, et al.
AIDS (London, England)|March 9, 2012
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing ageEric N Ouattara, Xavier Anglaret, Angela Y Wong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2011
Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'IvoireEugène Messou, Martial Kouakou, Delphine Gabillard, et al.
BMC Infectious Diseases|January 30, 2022
Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adultsDesmorys Raoul Moh, Jean-Baptiste Ntakpé, Delphine Gabillard, et al.
Antiviral Therapy|April 9, 2015
Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'IvoireAnders Boyd, Raoul Moh, Delphine Gabillard, et al.
BMJ Open|January 12, 2024
Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation modelAmir M Mohareb, Arthur Y Kim, Anders Boyd, et al.
Journal of Clinical Microbiology|June 16, 2005
Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited settingFrancois Rouet, Didier K Ekouevi, Marie-Laure Chaix, et al.
Plos Medicine|October 28, 2009
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalElena Losina, Hapsatou Touré, Lauren M Uhler, et al.
Plos One|June 6, 2017
High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'IvoireCalixte Ghehi, Delphine Gabillard, Raoul Moh, et al.
Antiviral Therapy|September 13, 2005
Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'IvoireRaoul Moh, Christine Danel, Souleymane Sorho, et al.
Pageof 17